Literature DB >> 22977517

Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells.

Minoru Tomizawa1, Fuminobu Shinozaki, Takao Sugiyama, Shigenori Yamamoto, Makoto Sueishi, Takanobu Yoshida.   

Abstract

To investigate the role of Activin A in the embryoid bodies (EBs) of human induced pluripotent stem (iPS) cells, EBs were transferred onto dishes coated with Matrigel after 4 days of incubation with Activin A and observed under a microscope. Alkaline phosphatase staining and immunostaining were performed to analyze the pluripotency of the cells, and the MTS assay was performed to analyze their proliferative potential. Fourteen days after EB formation, cells cultured with Activin A (100 ng/ml) showed no morphological alterations. Cells cultured with 10-100 ng/ml of Activin A were positive for alkaline phosphatase staining, while cells cultured with 0-3 ng/ml showed negative staining. Cells cultured with 10 ng/ml of Activin A were positive for Oct3/4, Nanog, SSEA-4 and TRA-1-60, while cells cultured with 0 ng/ml Activin A were negative. Cells cultured with 3-30 ng/ml of Activin A maintained their proliferative potential, while loss of proliferative potential was observed in cells cultured with 100 ng/ml Activin A. In conclusion, Activin A maintained pluripotency markers in human iPS cells cultured as EBs with Activin A.

Entities:  

Year:  2011        PMID: 22977517      PMCID: PMC3440779          DOI: 10.3892/etm.2011.219

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  15 in total

1.  Efficient differentiation of human embryonic stem cells to definitive endoderm.

Authors:  Kevin A D'Amour; Alan D Agulnick; Susan Eliazer; Olivia G Kelly; Evert Kroon; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2005-10-28       Impact factor: 54.908

2.  Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers.

Authors:  Gillian M Beattie; Ana D Lopez; Nathan Bucay; Andrew Hinton; Meri T Firpo; Charles C King; Alberto Hayek
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

3.  Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine.

Authors:  Minoru Tomizawa; Yoshiro Toyama; Chizuru Ito; Kiyotaka Toshimori; Katsuro Iwase; Masaki Takiguchi; Hiromitsu Saisho; Osamu Yokosuka
Journal:  Cell Tissue Res       Date:  2008-05-14       Impact factor: 5.249

4.  Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures.

Authors:  G Thomsen; T Woolf; M Whitman; S Sokol; J Vaughan; W Vale; D A Melton
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

5.  Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells.

Authors:  Lei Xiao; Xuan Yuan; Saul J Sharkis
Journal:  Stem Cells       Date:  2006-02-02       Impact factor: 6.277

6.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.

Authors:  Daylon James; Ariel J Levine; Daniel Besser; Ali Hemmati-Brivanlou
Journal:  Development       Date:  2005-02-09       Impact factor: 6.868

Review 7.  Activin A-induced differentiation of embryonic stem cells into endoderm and pancreatic progenitors-the influence of differentiation factors and culture conditions.

Authors:  Sabine Sulzbacher; Insa S Schroeder; Thuy T Truong; Anna M Wobus
Journal:  Stem Cell Rev Rep       Date:  2009-03-05       Impact factor: 5.739

8.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.

Authors:  Noboru Sato; Laurent Meijer; Leandros Skaltsounis; Paul Greengard; Ali H Brivanlou
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

9.  Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells.

Authors:  Ludovic Vallier; Thomas Touboul; Stephanie Brown; Candy Cho; Bilada Bilican; Morgan Alexander; Jessica Cedervall; Siddharthan Chandran; Lars Ahrlund-Richter; Anne Weber; Roger A Pedersen
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

10.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

Authors:  Hesham Basma; Alejandro Soto-Gutiérrez; Govardhana Rao Yannam; Liping Liu; Ryotaro Ito; Toshiyuki Yamamoto; Ewa Ellis; Steven D Carson; Shintaro Sato; Yong Chen; David Muirhead; Nalu Navarro-Alvarez; Ronald J Wong; Jayanta Roy-Chowdhury; Jeffrey L Platt; David F Mercer; John D Miller; Stephen C Strom; Naoya Kobayashi; Ira J Fox
Journal:  Gastroenterology       Date:  2008-10-29       Impact factor: 22.682

View more
  5 in total

1.  Chemically Defined Media Can Maintain Pig Pluripotency Network In Vitro.

Authors:  Kwang-Hwan Choi; Dong-Kyung Lee; Sung Woo Kim; Sang-Ho Woo; Dae-Yong Kim; Chang-Kyu Lee
Journal:  Stem Cell Reports       Date:  2019-06-27       Impact factor: 7.765

2.  A cytokine screen using CRISPR-Cas9 knock-in reporter pig iPS cells reveals that Activin A regulates NANOG.

Authors:  Junjun Xu; Zheng Zheng; Xuguang Du; Bingbo Shi; Jichang Wang; Dengfeng Gao; Qianqian Zhu; Xinze Chen; Jianyong Han
Journal:  Stem Cell Res Ther       Date:  2020-02-18       Impact factor: 6.832

3.  Genetic stability of pluripotent stem cells during anti-cancer therapies.

Authors:  Wiktoria Maria Suchorska; Ewelina Augustyniak; Magdalena Łukjanow
Journal:  Exp Ther Med       Date:  2016-01-13       Impact factor: 2.447

Review 4.  Cell-based therapies of liver diseases: age-related challenges.

Authors:  Konstantin N Yarygin; Alexei Y Lupatov; Irina V Kholodenko
Journal:  Clin Interv Aging       Date:  2015-12-01       Impact factor: 4.458

5.  Endodermal differentiation of human induced pluripotent stem cells using simple dialysis culture system in suspension culture.

Authors:  Marie Shinohara; Hyunjin Choi; Masato Ibuki; Shigeharu G Yabe; Hitoshi Okochi; Atsushi Miyajima; Yasuyuki Sakai
Journal:  Regen Ther       Date:  2019-05-30       Impact factor: 3.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.